An unusual cause of palpitations requiring atrioventricular node ablation and pacemaker therapy

Blood Pressure

Volumn 6, Issue 6, 1997, Pages 368-371

  Lydakis, Charalampos ^a   Hollinrake, Ken ^b   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b GEORGE ELIOT HOSPITAL   (United Kingdom)

Author keywords

Atrioventricular node ablation; Pacemaker; Pheochromocytoma

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; CATECHOLAMINE; DIGOXIN; DISOPYRAMIDE; MEXILETINE; NORADRENALIN; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CATECHOLAMINE URINE LEVEL; CATHETER ABLATION; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART PALPITATION; HUMAN; IMPLANTATION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR DIAGNOSIS;

EID: 0031416946     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059709062097     Document Type: Article

References (30)

1. Frankel F. Ein Fall von doppelseitigem, volliglatent verlaufenen Nebennierentumor und gleichzeitiger Nephritis mit Veranderungen am Circulationsapparat und Retinitis. Virchows Ach Pathol Anat Physiol 1886; 103: 244-63.
2. Manger WM, Gillford RW. Pheochromocytoma. New York: Springer-Verlag, 1977: 398.
3. Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT. Occurrence of pheochromocytoma in Rochester Minnesota, 1950 through 1979. Mayo Clin Proc 1983; 58: 802-4.
4. Orchard T, Grant C, van Heerden JA, Weaver A. Pheochromocytoma - continuing evolution of surgical therapy. Surgery 1993; 114: 1153-9.
5. Sutton M StJ, Sheps SG, Lie JI. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981; 56: 354-60.
6. Stenstrom G, Svarsudd K. Pheochromocytoma in Sweden 1958-1981. Acta Med Scand 1986 (Suppl 220): 225-32.
7. Ross EJ, Griffith DNW. The clinical presentation of pheochromocytoma. Q J Med 1989; 266: 485-96.
8. Manger DM, Gifford RW. Pheochromocytoma: a clinical overview. In: Swales JD, eds. Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994: 946.
9. Plouin P, Degoulet P, Tugaye A, Ducrocq M, Menard J. Le depistage du pheochromocytome: Chez quels hypertendus? Nouv Press Med 1981; 10: 869-72.
10. Plouin P, Chatellier G, Rougeot M, Duclos J, Pagny J, Corvol P, Menard J. Recent developments in pheochromocytoma diagnosis and imaging. Adv Nephrol 1988; 17: 275-86.
11. Starkman MN, Zelnick TC, Nesse RM, Cameron OG. Anxiety in patients with pheochromocytoma. Arch Intern Med 1985; 145: 248-52.
12. Moorhead EL, Caldwell JR, Kelly AR, Morales AR. The diagnosis of pheochromocytoma. JAMA 1966; 196: 1107-13.
13. Radke WE, Kazmier FJ, Rutherford BD, Sheps SG. Cardiovascular complications of pheochromocytoma crisis. Am J Cardol 1975; 35: 701-5.
14. Das S, Bulusa NV, Lowe P. Primary vesical pheochromocytoma. Urology 1983; 21: 20-5.
15. Zimmerman IJ, Biron RE, MacMahon HE. Pheochromocytoma of the urinary bladder. N Engl J Med 1953; 125: 249-53.
16. Steiner AI, Goodman AD, Powers SR. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's syndrome: multiple endocrine neoplasia type 2. Medicine 1968; 47: 371-409.
17. Shimizu K, Miura Y, Meguro Y, Noshiro T, Ohzeki T, Kusakari T, et al. QT prolongation with torsade de pointes in pheochromocytoma. Am Heart J 1992; 124: 235-9.
18. Huang S, Rosenberg M, Denes P. Short PR interval and narrow QRS complex associated with pheochromocytoma: electrophysiologic observations. J Am Col Cardiol 1984; 3: 872-5.
19. Michaels RD, Hays JH, O'Brian JT, Shakir KM. Pheochromocytoma associated ventricular tachycardia blocked with atenolol. J Endocrinol Invest 1990; 13: 943-7.
20. Gurlek A, Erol C. Pheochromocytoma with asymmetrical septal hypertrophy and Wolff-Parkinson-White syndrome. Int J Cardiol 1991; 32: 403-5.
21. Gordon DL, Atamian SD, Brooks MH, Gattuso P, Castelli MJ, Valaitis J, et al. Fever in pheochromocytoma. Arch Intery Med 1992; 152: 1269-72.
22. Hicks RJ, Wood B, Kalff V, Anderson ST, Kelly MJ. Normalisation of left ventricular ejection fraction following resection of pheochromocytoma in a patient with dilated cardiomyopathy. Clin Nucl Med 1991; 16: 413-16.
23. Imperato McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with pheochromocytoma. N Engl J Med 1987; 316: 793-97.
24. Schuiki ER, Jenni R, Amann FW, Ziegler WH. A reversible form of apical ventricular hypertrophy associated with pheochromocytoma. J Am Soc Echocardiol 1993; 6: 327-31.
25. Wilkenfeld C, Cohen M, Lansman SL, Courtney M, Dische MR, Pertsemlidis D, et al. Heart transplantation for end-stage cardiomyopathy caused by an occult pheochromocytoma. J Heart Lung Transpl 1992; 11: 363-6.
26. Nirgiotis JG, Andrassy RJ. Pheochromocytoma and acute myocardial infarction. South Med J 1990; 83: 1478-80.
27. Krane K. Clinically unsuspected pheochromocytomas. Experience at Henry Ford Hospital and a review of the literature. Arch Intern Med 1986; 146: 54-7.
28. Stein P, Black H. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine 1990; 70: 46-66.
29. Taubman I, Pearson O, Anton A. An asymptomatic catecholamine-secreting pheochromocytoma. Am J Med 1974; 57: 953-6.
30. Melikow M. One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976. Cancer 1977; 40: 1987-2004.